FollowLatest SEC filingSEC filer historyProfile details as reported on 2026-11-20.Following & alerts
- Reported transaction lines
- 1
- Buy lines
- 0
- Sell lines
- 0
Filing activity by month
Original filing lines in up to 12 months with activity.
- 2026-111
Frequently disclosed stocks
Disclosure history
| Reporting investor | Security | Activity | Transaction / period | Filed | Reported amount | Source |
|---|---|---|---|---|---|---|
| Leong Justin Chief Product Officer · RESMED INC | RMD RESMED INC | Equity grant or awardFiling detailsSEC transaction code A ResMed Common Stock · Direct ownership · Reported balance after transaction: 10314 · Represents performance-based restricted stock units granted on November 16, 2023. The shares were earned on November 19, 2026, when the compensation and leadership development committee certified that the performance metrics were met for this portion of the grant. | 2026-11-19 | 2026-11-20 | 10,314 shares/units | SEC 4 |
Counts describe original filing lines in BriefStock’s coverage. Later amendments can correct or supplement them. Check the original filing for ownership and transaction details.
Advertisement